Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
FDA issues CRL for vatiquinone to treat Friedreich ataxia
PODCAST: Auditory brain stem implants in young children.
A headache with a red flag in a 10-year-old girl
Phase 3 trial of omaveloxolone to treat Friedreich ataxia in children aged 2 to <16 begins
Full recap from the 2025 Pediatric Academic Societies meeting
Youth with neurodevelopmental disabilities face higher risk of poor cardiovascular health